Abstract
No public abstract is available from the verified source records.
Tiphaine Adamde Beaumais, Yahia Adnani, Léa Guerrini-Rousseau, Samuel Abbou, Cécile Acquaviva-Bourdain, Pablo Berlanga, Adeline Bonnard, Gaelle Bougeard, Franck Bourdeaut, Nelly Burnichon, Sandrine Caputo, Olivier Caron, Hélène Cavé, Albain Chansavang, Nadège Corradini, Sophie Cotteret, Philippe Denizeau, Alice Fievet, Mathilde Filser, Thierry Frébourg, Marion Gauthier-Villars, Birgit Geoerger, Nadim Hamzaoui, Edwige Kasper, Florence Kyndt, Ludovic Lacroix, Jessica Le Gall, Julien Masliah-Planchon, Laurence Pacot, Cécile Pagan, Mélanie Pages, Béatrice Parfait, Eric Pasmant, Gaelle Pierron, Pascale Richard, Nathalie Roux-Buisson, Cécile Saint-Martin, Hela Sassi, Gudrun Schleiermacher, Nancy Uhrhammer, Dominique Vidaud, Laurence Brugières, Gilles Vassal, Etienne Rouleau, Yoann Vial, Lisa Golmard, Odile Cabaret
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Molecular screening for cancer treatment optimization (MOSCATO-01) in pediatric patients: a single-institution prospective molecular stratification trial
10.1158/1078-0432.ccr-17-0381 · 2017
The European MAPPYACTS trial: precision medicine program in pediatric and adolescent patients with recurrent malignancies
10.1158/2159-8290.cd-21-1136 · 2022
The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets
10.1158/2159-8290.cd-21-0094 · 2021
Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome, and transcriptome
10.1038/s41467-018-06485-7 · 2018
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer
10.1038/s41591-020-1072-4 · 2020
Right to know and right to ignore in paediatric oncogenetics: identifying biological causes or seeking for meaning?
10.1016/j.ejca.2016.04.021 · 2016
Germline rare variants in cancer susceptibility genes and subsequent neoplasm risk after childhood cancer
10.1093/jnci/djaf260 · 2025
The landscape of genomic alterations across childhood cancers
10.1038/nature25480 · 2018
Germline mutations in predisposition genes in pediatric cancer
10.1056/nejmoa1508054 · 2015
Implementation of paediatric precision oncology into clinical practice: the individualized therapies for children with cancer program (iTHER)
10.1016/j.ejca.2022.09.001 · 2022
10.1158/1078-0432.ccr-17-0702
10.1158/1078-0432.ccr-17-0702
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
10.1038/gim.2013.73 · 2013
ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing
2022
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
SPiP: splicing prediction pipeline, a machine learning tool for massive detection of exonic and intronic variant effects on mRNA splicing
10.1002/humu.24491 · 2022
RNA-based diagnostic studies in genetics: review and guidance from a multidisciplinary French network
10.1038/s41431-025-01881-2 · 2025
Frequency of pathogenic germline variants in cancer-susceptibility genes in the Childhood Cancer Survivor Study
10.1093/jncics/pkab007 · 2021
Cancer predisposition syndromes as a risk factor for early second primary neoplasms after childhood cancer: a national cohort study
10.1016/j.ejca.2020.11.042 · 2021
Frequency of pathogenic germline variants in cancer-susceptibility genes in patients with osteosarcoma
10.1001/jamaoncol.2020.0197 · 2020
Revisiting Li-Fraumeni syndrome from TP53 mutation carriers
10.1200/jco.2014.59.5728 · 2015
Occurrence of neuroblastoma among TP53 p.R337H carriers
10.1371/journal.pone.0140356 · 2015
Comparison of the frequency of loss-of-function LZTR1 variants between schwannomatosis patients and the general population
10.1002/humu.24376 · 2022
10.1016/j.lanepe.2024.101183
10.1016/j.lanepe.2024.101183
Systematic discovery of germline cancer predisposition genes through the identification of somatic second hits
10.1038/s41467-018-04900-7 · 2018
ACMG SF v3.3 list for reporting of secondary findings in clinical exome and genome sequencing
2025
Psychological and ethical issues raised by genomics in paediatric care pathways: a qualitative analysis with parents and childhood cancer patients
10.1038/s41431-024-01653-4 · 2024
Expectations, needs and mid-term outcomes in people accessing secondary findings from exome sequencing: first French mixed study (FIND study)
10.1038/s41431-024-01616-9 · 2024
Secondary findings in hereditary cancer genes after germline genetic testing: a systematic review of the literature
10.1007/s00439-025-02746-w · 2025
No additional external references are available.